SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-07-060866
Filing Date
2007-08-09
Accepted
2007-08-09 15:50:57
Documents
10
Period of Report
2007-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a07-18255_110q.htm 10-Q 879300
2 EX-10.1 a07-18255_1ex10d1.htm EX-10.1 48617
3 EX-10.2 a07-18255_1ex10d2.htm EX-10.2 490395
4 EX-10.3 a07-18255_1ex10d3.htm EX-10.3 101437
5 EX-10.4 a07-18255_1ex10d4.htm EX-10.4 41375
6 EX-10.5 a07-18255_1ex10d5.htm EX-10.5 71118
7 EX-31.1 a07-18255_1ex31d1.htm EX-31.1 9265
8 EX-31.2 a07-18255_1ex31d2.htm EX-31.2 9273
9 EX-32.1 a07-18255_1ex32d1.htm EX-32.1 6527
10 GRAPHIC g182552kl09i001.gif GRAPHIC 1677
  Complete submission text file 0001104659-07-060866.txt   1661070
Mailing Address
Business Address 130 WAVERLY STREET CAMBRIDGE MA 02139-4242 6165776000
VERTEX PHARMACEUTICALS INC / MA (Filer) CIK: 0000875320 (see all company filings)

IRS No.: 043039129 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19319 | Film No.: 071040247
SIC: 2834 Pharmaceutical Preparations